BASF, Offloads

BASF Offloads Mining Solutions Unit as Jefferies Keeps Bearish Stance After Evonik Exit

Published on 11/20/2026 at 06:31 | Editorial boerse-global.de
BASF will sell its Mining Solutions unit to SNF, closing in 2027, after dropping its EUR 24-per-share Evonik bid; Jefferies keeps Underperform at EUR 44.
BASF, Offloads, Mining, Solutions, Unit, Jefferies, Keeps, Bearish, Stance, After Illustration mit AI erstellt.

BASF has agreed to sell its global Mining Solutions business to SNF, a transaction that hands the French specialty chemicals group a production site in Cork along with roughly 140 employees. The Ludwigshafen-based company expects the deal to close in 2027, subject to regulatory clearance and the usual closing conditions.

The divestment caps a busy stretch for BASF, which only a day earlier walked away from its pursuit of Evonik after the Essen-based group turned down two unsolicited all-cash offers. BASF's final bid stood at EUR 24 per Evonik share, and while the company had signalled a further moderate increase was possible, management drew the line there, judging that a richer price would not serve its own shareholders.

Buyback Rolls On

Shareholder returns remain a parallel track. BASF reported on 16 November the repurchase of about 591,000 of its own shares during the 9 to 13 November window. Since the programme began on 3 August, the group had bought back roughly 8.54 million shares by the end of that period.

The Evonik retreat initially lifted the stock, though the gains faded and the shares finished yesterday's session down 1.1%.

Should investors sell immediately? Or is it worth buying BASF?

Jefferies Unmoved

Jefferies reaffirmed its "Underperform" rating and EUR 44 price target yesterday. The analyst acknowledged strategic merits in a Evonik takeover but flagged BASF's heavy exposure to Europe and the execution risk attached to delivering synergies. With the bid withdrawn, neither the upside the broker had identified nor the synergy risk now applies — yet the unchanged rating makes clear the pullback was no reason to turn more constructive on the stock.

That leaves the operating margin as the yardstick for investors. Without Evonik, the question is whether BASF can grow more profitably through its own investments and products; extra capacity or higher sales alone will not suffice.

Geismar Is the Test Case

The clearest gauge sits in Louisiana, where BASF has brought a new MDI plant at its Geismar site on stream. The company put the investment at around USD 1 billion and the site's annual MDI capacity after the expansion at roughly 600,000 tonnes. Commissioning is complete. Whether the build-out lifts profitability depends on how well BASF runs the added capacity and at what prices it sells the output. Higher utilisation on its own would not prove a better margin — the additional volumes need to deliver a correspondingly larger operating profit contribution.

In the favourable scenario, BASF sells the extra Geismar production without conceding on price, so the plant lifts revenue and, through better utilisation, supports profitability. A weak outcome would see the added volumes move slowly or at softer prices, spreading fixed costs over less output; even with rising utilisation, price concessions could cap the earnings contribution. In either case, sales growth would be a weaker signal than it first appears.

Nemasphere Adds a Second Growth Lever

Agriculture offers another potential contributor. BASF is pushing the global rollout of its Nemasphere soybean trait, with varieties carrying the trait due to be available in the US and Brazil from 2028. BASF puts the peak sales potential at more than EUR 300 million. That figure describes a possible top-line size at the peak, not an expected revenue at launch — for the margin case, what would matter is the earnings contribution the product could generate.

BASF at a turning point? This analysis reveals what investors need to know now.

Neither project offers a quick offset. Reaching peak sales is not the same as the planned availability date, so anyone treating both as arguments for higher profitability must clear two separate hurdles: profitable sales of additional volumes at Geismar and the later commercialisation of the soybean trait.

January Brings a Milestone

A concrete date for delivering on an operational plan comes in January 2027, when BASF intends to make its European Oppanol B and Glissopal products for external customers entirely with electricity from renewable sources. The switch has been announced; carrying it out would mark tangible progress on that front, though on its own it is no signal of a higher operating margin. For investors, the decision is whether to price in a margin improvement now or wait for visible earnings evidence.

Ad

BASF Stock: New Analysis - 20 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer...
en | DE000BASF111 | BASF | boerse | 70538674 |